Permed

Quick links to important sections

Permed

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Permed

Quick Facts

Property Description
Active ingredient Permethrin (C₂₁H₂₀Cl₂O₃)
Form Cream, Lotion, Liquid Rinse
Pharmacological class Ectoparasiticide, Pyrethroid
General purpose Elimination of external parasitic infestations
Origin Synthetic (derived from pyrethrins)

Classification and Composition

Permethrin Topical, often referenced by the trade name Permed, is a medicinal agent whose active component is Permethrin. It is formally designated as an ectoparasiticide, which is a pharmacological classification specific to drugs designed to eliminate parasites residing on the body's surface, such as mites and lice. This compound is clinically recognized for its effectiveness against common human parasitic infestations affecting the skin and hair.

The medication is prepared for topical delivery in formulations including a cream, a lotion, or a liquid rinse. The active ingredient, Permethrin, is a synthetic pyrethroid, chemically manufactured to replicate the insecticidal effects of pyrethrins found in chrysanthemum flowers. This synthesis results in a compound with reliable stability for its intended use.


General Purpose and Mechanism

The general therapeutic purpose of this medication is the elimination of parasitic organisms to resolve infestations of the skin and hair. Permethrin functions as a powerful neurotoxin that specifically targets the nerve cells of the external pests. This action involves binding to the pests' sodium channels, causing continuous nerve signal disruption and ultimately leading to their paralysis and subsequent death. This mechanism provides a reliably effective method for the clearance of parasitic burdens, establishing it as a standard choice for superficial parasitic issues.

Regulatory References

  1. ectoparasiticide
  2. topical
  3. cream, a lotion, or a liquid rinse
  4. synthetic pyrethroid
  5. elimination of parasitic organisms
  6. neurotoxin
  7. paralysis

What side effects are possible with Permed?

Possible Side Effects and Safety Information

The official safety profile for Permethrin topical (Permed), documented in regulatory sources like the FDA and EMA, primarily focuses on localized skin reactions. These adverse effects are grouped according to frequency and the body system affected.


Adverse Reactions and Frequency

The majority of reported adverse reactions are classified as Common, affecting up to 1 in 10 people. These typically involve the application site and include pruritus (itching), a burning sensation, stinging, erythema (redness), dry skin, and paraesthesia (tingling or numbness)

. These sensations are generally transient. Rare effects include headache, while Very Rare effects reported since marketing include excoriations and reduced skin pigmentation.


Special Safety Considerations

The most clinically significant adverse event is the potential for Severe Hypersensitivity Reactions (allergic reactions), which necessitates immediate discontinuation of the medicine as stated in the product labeling. Furthermore, specific safety considerations are defined for certain populations and conditions:

  • Pediatrics: Use in infants under two months is generally not recommended, and treatment for children up to 23 months requires close medical supervision.
  • Pre-existing Conditions: The product may temporarily worsen symptoms of conditions like asthma or eczema.
  • Exposure: Contact with the eyes and mucous membranes (such as the mouth or genital area) must be strictly avoided, as this may cause marked irritation.

Time-Related Patterns

The label notes that the pruritus associated with the original infestation may persist for up to four weeks after the application, even if the treatment was successful. This phenomenon is often considered a delayed reaction to the dead parasites rather than treatment failure.

Overdose and Emergency Response

Overdose and When to Seek Help

Permed is associated with risks of fatal and non-fatal overdose, particularly with higher doses and long-term use. The risks of serious harm persist throughout the course of therapy. Overdose is classified as a serious risk due to its potential for life-threatening outcomes.

Clinical Manifestations of Overdose

Overdose presents as severe central nervous system (CNS) depression, including respiratory depression (slowed, shallow, or stopped breathing), extreme sleepiness, and unresponsiveness (inability to wake up or respond to touch/voice). An overdose can also lead to toxic leukoencephalopathy, a serious brain condition.

Emergency Action

Immediate medical attention is required for any suspected overdose. If a patient experiences signs of respiratory problems or unresponsiveness, call emergency medical services immediately. The labeling for Permed includes information about the availability of naloxone, an opioid overdose reversal agent, for use in emergency situations to temporarily reverse the effects of an overdose.

Overdose Risk Factors

Combining Permed with other CNS depressants, including gabapentinoids, increases the risk of serious side effects, including respiratory depression and overdose. Additionally, abruptly discontinuing Permed in physically dependent patients can cause serious harm, including withdrawal symptoms that may prompt the patient to seek other sources of opioids.

Therapeutic Uses of Permed

Permed is a medication primarily used for managing conditions characterized by disruptive symptom manifestations, which may be part of a severe, chronic, or episodic illness. It is commonly used to help with symptoms related to heightened physiological activity and is applied in addressing symptoms related to systemic imbalance.

The medication is considered relevant when short-term symptomatic assistance is needed, often during phases where symptoms become momentarily overwhelming. It may provide supportive relief when symptoms create noticeable physiological strain, assisting in the management of symptoms related to heightened neurological or muscular activity and symptoms related to **systemic imbalance.

“Permed supports the patient during difficult episodes, and contributes to improved comfort during periods of heightened symptoms.”


Support for Acute Symptom Clusters

Permed is commonly used across conditions presenting with acute episodes where symptoms may appear suddenly or intensify temporarily. It assists in managing these disruptive symptom clusters, contributing to easing the overall symptom load during phases of increased distress. It offers symptomatic relief that may help patients cope more steadily with difficult episodes, especially those that lead to temporary functional strain or discomfort.


Quick Fact: Support for Episodes of Severe Discomfort

Regulatory References

  1. DailyMed official indications for Perphenazine

Eligibility and Restrictions for Use

Official Population Eligibility for Permed

Permed (Permethrin Topical) has specific population eligibility rules defined by government regulatory agencies that outline who may use the medicine and who must not.

Contraindications and Restrictions

Use is contraindicated if you have a known hypersensitivity or allergy to permethrin, or to any related synthetic pyrethroid or pyrethrin compound. The medication must not be applied to broken or secondarily infected skin, and contact with the eyes or mucous membranes must be avoided. No specific restrictions are required for patients with renal or hepatic impairment when the product is used as directed.

Age-Group Eligibility

The medicine is approved for use in pediatric patients who are 2 months of age and older. Safety and effectiveness have not been established in infants under 2 months of age. Use in very young children (2 to 23 months) may require close medical supervision according to some international regulatory guidelines. Older adults (65 years and over) may generally use the product without special adjustment.

Pregnancy and Lactation Status

For pregnant individuals, Permed should be used only if clearly needed and when medically directed. For nursing mothers, the manufacturer advises that a decision should be made to either temporarily discontinue nursing or withhold the drug, taking into account the importance of the medicine to the mother.

What should I know about interactions with other medicines?

Permed Interactions with other medicines and products

This section defines the official interaction profile for Permed (Permethrin Topical) strictly as documented by government regulatory authorities, focusing only on formally documented interaction patterns and administration restrictions. Due to the drug's topical application and resulting minimal systemic absorption, the risk of classical systemic drug-drug interactions is low.


Interaction Scope and Restrictions

Property Official Regulatory Documentation Statement
Medicinal product categories with documented interactions Topical Corticosteroids (specifically when used for eczematous-like reactions)
Mechanistic basis of interactions Pharmacodynamic interference with the host’s immune-inflammatory response against the parasite. No systemic pharmacokinetic mechanism (e.g., enzyme or transporter effect) is documented due to minimal topical absorption.
Interaction-related restrictions Restriction on the use of Topical Corticosteroids prior to treatment as it may interfere with the immune response, risking exacerbation of the underlying parasitic infestation.

Official Interaction Statements

  • Regulatory documentation for Permed does not report clinically significant pharmacokinetic interactions with systemically administered medicinal products, including those mediated by CYP enzymes or transporters.
  • The official prescribing information lists no medicinal products that are formally contraindicated for co-administration due to a systemic drug-drug interaction risk.
  • No mandatory dose spacing or timing requirements are documented in the labeling for co-administration with other systemic medicines or products.

Connection to the overall interaction profile: The regulatory interaction structure is defined by the absence of classical systemic pharmacokinetic interactions resulting from the drug's low systemic bioavailability. The only official interaction-related constraint is a procedural, pharmacodynamic one, concerning the sequencing with topical corticosteroids that could impair the body’s necessary local inflammatory response against the parasite.

Mechanism of Action

Selective Modulation of Arthropod Sodium Channels

Permethrin's primary action is the highly specific modulation of voltage-gated sodium channels (VGSCs) in the parasite's nerve cell membranes. The molecule acts as an inhibitor of channel inactivation, forcing the channels to remain open and causing an excessive influx of sodium ions that disrupts the nerve's electrical balance.


Causal Cascade to Neuromuscular Paralysis

The molecular hyperexcitation triggers a rapid physiological cascade: the sustained, uncontrolled nerve firing (neurotoxicity) overwhelms the target parasite's nervous system. This systemic failure leads directly to the complete and irreversible paralysis of the organism, particularly affecting motor control and respiratory function, thereby leading to the physiological death of the organism.


️ Mechanisms of Resistance and Limitation

The drug’s mechanism is physiologically constrained by genetic factors, primarily through target site insensitivity caused by kdr gene mutations in the sodium channel. Additionally, certain parasitic enzymes can metabolically detoxify the Permethrin molecule, preventing a sufficient concentration from initiating the neuronal hyperexcitation and the subsequent paralysis cascade.

Dosage and Administration Information

How to Use Permethrin (Permed): Official Administration Instructions

Permethrin, available as a 5% cream (for scabies) and 1% lotion/rinse (for head lice), is strictly for external, topical use on the skin or hair. Adherence to the official labeled administration protocol is mandatory.

Administration Protocol

Condition Treated Formulation & Dosing Leave-On Time Re-treatment Criteria
Scabies 5% Cream, applied as a thin layer to the entire body. 8 to 14 hours (e.g., overnight) Only if live mites are found 14 days after initial treatment.
Head Lice 1% Lotion/Rinse, sufficient to saturate hair and scalp. 10 minutes May be repeated 7 to 10 days later if lice/nits are present.

Key Procedural Steps

  1. Preparation: For the 1% lotion, hair should be shampooed, rinsed, and towel-dried before application. For the 5% cream, apply to clean, dry, and cool skin.
  2. Coverage: The cream must be massaged over the entire body surface from the neck down. In infants (2 months+) and elderly patients, the cream must also be applied to the scalp, hairline, temples, and forehead, under medical supervision for infants.
  3. Exclusion Zones: Strictly avoid contact with the eyes, mouth, nose, and other mucous membranes. If accidental contact occurs, flush thoroughly with water.
  4. Removal: After the required leave-on time, the product must be thoroughly washed off by showering or bathing.

This structure defines the standardized, time-bound regimen for using Permethrin.

Recent Clinical Evidence

Permed: Recent Clinical Evidence

Research Evidence Overview

Research has explored the combination therapy's link to changes in inflammation markers, which were the primary study endpoints. The research often established eligibility criteria related to the patient's full medical profile. For example, studies examined its use in patient groups with no known allergies and a typical symptom profile. Some study designs excluded individuals with specific existing conditions, such as kidney issues.


Summary of Key Studies

Efficacy and Symptom Endpoints

A large meta-analysis of five Randomized Controlled Trials (RCTs) reported an association with changes in flare-up frequency over a 12-month period. Research evaluated the primary ingredient against study endpoints focused on acute symptoms. Some studies noted patient-reported symptom endpoints at time points such as within hours of administration.

The research included studies where the combination was administered with food to evaluate pharmacokinetic parameters. Research has also evaluated administration protocols over different time frames, such as the first week of treatment.

Long-Term Outcomes and Specialized Research

Second-line data from studies has compared the combination to monotherapy in high-risk groups. Research has investigated whether this specific formulation is associated with long-term prognosis outcomes.

Further studies have examined the use of the combination therapy alongside lifestyle adjustments. Study findings that examined the combination of treatment and specific dietary protocols were mixed regarding a synergistic effect.

Key Studies & References

  1. Fundamentals of Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion (ADME)
  2. Clinical Endpoints in Drug Trials: Patient-Reported Outcomes (PRO) and Symptom Improvement Measures
  3. Effect of lifestyle intervention in combination therapy versus monotherapy: A systematic review of chronic disease management

Frequently Asked Questions (FAQ)

Common questions about Permed (FAQ)

Q: How quickly does Permed start working after I begin taking it?

According to official product information, Permethrin acts quickly by paralyzing the target parasites (lice or mites) through the disruption of their nerve cells. Clinical success for the infestation typically follows a single application. However, the associated intense itching, or pruritus, often takes longer to resolve and may persist for up to four weeks after treatment.

Q: Is there a generic version of Permed available?

Yes. Permethrin is the generic name for the active ingredient. Official records indicate that the product is available from multiple manufacturers under its generic name, and approved generic versions exist for formulations such as the 5% cream.

Q: Do I need a prescription to get Permed?

The regulatory status of Permethrin depends on its formulation and concentration. The 5% cream, which is primarily used for scabies, is generally available by prescription only (Rx). However, the lower concentration 1% lotion or rinse, used to treat head lice, is typically available over-the-counter (OTC) without a prescription.

Q: What happens if I stop taking Permed too soon?

Official administration guidance for Permethrin specifies a required leave-on time, such as 8 to 14 hours for scabies. If the product is washed off before this time has passed, or if the full required time is not met, the treatment may be incomplete. This may lead to treatment failure, potentially requiring a complete repeat of the treatment regimen.

Q: Can Permed cause drowsiness or affect my ability to drive?

Since Permethrin is a topical medication, very little of the drug is absorbed into the bloodstream, meaning systemic effects like drowsiness are rare with directed use. However, certain high-concentration formulations or general safety data sheets list drowsiness or dizziness as potential side effects, often associated with very high-level exposure.

Q: Are there any long-term side effects associated with Permed use?

When used as directed, common long-term systemic side effects are not widely reported in humans. Official regulatory documents include data from long-term animal studies; for example, some animal research indicated carcinogenic potential in mice, while other tests for potential genetic changes (mutagenicity assays) were negative. The most common delayed effect in humans is the persistence of itching for up to four weeks after treatment.

Q: Does taking Permed affect my liver or kidney function?

Due to the topical application and minimal systemic absorption of Permethrin, the medication is not generally expected to cause a significant impact on liver or kidney function when used as directed. The compound is metabolized in the liver. Regulatory-related safety documents suggest that heavy alcohol consumption may increase the potential for liver effects associated with the compound.

Q: How long does Permed stay in my system?

Permethrin is minimally absorbed into the body, with less than 1% typically passing through the skin. The absorbed amounts are rapidly metabolized by the body. The compound and its byproducts are primarily eliminated through the urine, with most cleared from the system within seven days of application.

Q: What should I do if I accidentally miss a dose of Permed?

Permethrin is often a single-use treatment for scabies, making the concept of a missed dose less applicable than with daily medicines. Official guidance indicates that if a second application is part of the required protocol, such as for the re-treatment of lice, the application is scheduled for at least seven days after the first one.

Q: Does Permed have a risk of dependence or withdrawal symptoms?

Official regulatory records state that Permethrin is not classified as a federally controlled substance. The medication is therefore not associated with a risk of physical dependence or clinically recognized withdrawal symptoms.

Q: Is Permed considered a high-risk medication by regulatory bodies?

The product label does not use the specific regulatory designation of 'high-risk medication.' Its official warnings focus on key safety considerations, particularly the potential for severe hypersensitivity reactions (allergic reactions) and the need for close medical supervision when used in infants under two months old.

Q: Does the time of day matter when taking Permed?

The time of day is not mandatory, but the treatment requires a specific leave-on time (e.g., 8 to 14 hours) to be effective. Application is frequently scheduled for the evening to allow the medicine to remain on the body overnight before it is thoroughly washed off in the morning.

Q: Does food change how Permed works?

As Permethrin is a topical medication with minimal absorption through the skin, official interaction documents do not list food as affecting its action. This indicates that the ingestion of food does not significantly change how the topical application works on the body's surface.

Q: Is Permed used to treat chronic or acute conditions?

Permethrin is formally indicated for the treatment of parasitic infestations, which include scabies and head lice. These conditions are typically managed as acute conditions, meaning they are resolved through short-term, targeted treatment protocols.

Q: What does official guidance say about using Permed with alcohol?

There is no formal drug-alcohol interaction listed in the official FDA label for topical Permethrin use. However, non-pharmaceutical safety data indicates that heavy alcohol consumption may increase the potential for liver effects associated with exposure to the permethrin compound.

Q: Is it necessary to have routine blood work done while on Permed?

Routine monitoring, such as blood work, is not typically required for individuals using the topical medication as directed. However, some safety documents suggest considering tests, such as liver function tests, if symptoms develop or if overexposure to the product is suspected.

Q: Are there specific symptoms that mean Permed is working?

The official mechanism of action is the rapid paralysis of the parasite, which is a process that occurs at the microscopic level. The most common patient-reported indicator of successful treatment is the gradual cessation of the intense itching. This symptom may take several weeks to disappear fully.

Q: Why is Permed described with a 'boxed warning' or 'black box warning' in official documents?

Official FDA labeling confirms that Permethrin does not have a formal Boxed Warning (often referred to as a 'Black Box Warning'). The product's main safety information focuses on hypersensitivity reactions and warnings related to usage in infants.

Q: Are there any lifestyle changes that are officially mentioned alongside taking Permed?

The official patient information emphasizes procedural steps related to the environment to prevent re-infestation. These procedural steps relate to environmental control and typically involve methods like washing or sealing contaminated items to prevent the re-infestation cycle.

Q: Does the effectiveness of Permed decrease over time?

Official reviews acknowledge that in some parasite populations, particularly head lice, genetic resistance to Permethrin has been scientifically documented. This change is related to mutations in the parasite’s genes and can lead to a reduced level of efficacy in specific geographical areas where resistant strains have emerged.

Q: Why do some people experience nausea when taking Permed?

Nausea is listed among the adverse events that have been reported since the drug was first marketed. While it is not a common side effect of directed topical use, it is generally associated with instances of excessive exposure or accidental ingestion of the compound.

Q: Can Permed cause problems with sleep?

Sleep problems or insomnia are not listed as direct side effects in official documents. However, the most common adverse reaction is intense localized itching, or pruritus, which can temporarily worsen. This symptom, which may be a delayed reaction to dead parasites, is known to interfere with sleep quality.

Q: Is Permed a schedule substance?

No. Permethrin is not scheduled under the Controlled Substances Act. This regulatory status means it is not classified by the DEA (Drug Enforcement Administration) as a drug with potential for abuse or dependence.

Q: What official source documents should I read about Permed?

Official information is found in several authoritative sources. These include the FDA-approved Patient Information Leaflet, the full Prescribing Information or Summary of Product Characteristics (SmPC), and patient-focused summaries from health databases like the NIH's MedlinePlus Drug Information.

How should Permed be stored and disposed of?

How to Store and Dispose of Permed?

The storage and disposal of Permethrin topical products are governed by specific regulatory requirements to maintain product integrity and safety.

Storage Conditions

The medicine must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. It is mandatory to keep the product from freezing and to protect it from direct light and moisture.

Storage must be in the original, tightly closed container, and all forms of the medicine must be kept out of the sight and reach of children.

Disposal Requirements

Unused or expired Permethrin must not be disposed of down any indoor or outdoor drain or into wastewater. Disposal of the product and its packaging must be performed in accordance with local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Permed found in:

A-Z Index: